Loading organizations...
Key people at Kingdon Capital.
Kingdon Capital was founded in 1983 by Mark E. Kingdon (President, CEO/Managing Member & Founder).
Mark E. Kingdon, founder, CEO, and chief portfolio manager, leads Kingdon Capital Management, a prominent New York, United States-based hedge fund. The firm operates as a long-running investment management entity, specializing in equities and other liquid assets across diverse public market sectors to generate substantial returns for its institutional and high-net-worth investors. Established by Mark E. Kingdon in 1983, it commenced operations with an initial capital of $2 million, charging both management and performance fees. Most recently, Kingdon Capital Management managed approximately $623 million in assets under management. This figure reflects a significant decrease from its historical peak of $5.9 billion in 2007 and $4 billion around 2010, yet highlights its enduring presence and long operational history in the financial markets.
Key people at Kingdon Capital.
Kingdon Capital was founded in 1983 by Mark E. Kingdon (President, CEO/Managing Member & Founder).
Kingdon Capital has 2 tracked investments across 2 companies. The latest tracked deal is $115.0M Other Equity in CeQur Simplicity in April 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 13, 2021 | CeQur Simplicity | $115.0M Other Equity | Credit Suisse, Endeavour Vision | Federated Kaufmann Fund, GMS Capital Partners, Schroders, John F. Sheridan, VI Partners, Ypsomed Group |
| Nov 19, 2020 | Imago BioSciences, Inc. | $80.0M Series C | Farallon Capital Management | Amgen Ventures, BlackRock, Blackstone, Frazier Healthcare Partners, Greenspring Associates, Irving Investors, MRL Ventures Fund, Omega Funds, Pharmaron, Surveyor Capital, T. Rowe Price Associates, Xeraya Capital |
